natgillin/translations-raw huggingface dataset:
If treatment is imperative in adolescents (from 12 to 17 years old), the posology should be the same as adults posology. 
Če je zdravljenje pri mladostnikih (v starosti od 12 do 17 let) nujno, mora biti odmerjanje enako kot pri odraslih.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL (IV- 50, 100 or 250 ml glass vials, 100 and 200 ml PVC bags) 
OZNAKA (IV 50, 100 ali 250 ml steklene viale, 100 in 200 ml vrečke iz PVC)
Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. 
Bolniki z redko dedno intoleranco za galaktozo, laponsko obliko zmanjšane aktivnosti laktaze ali malabsorpcijo glukoze/galaktoze tega zdravila ne smejo jemati.
Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. 
Bolniki z redko dedno intoleranco za fruktozo, malabsorpcijo glukoze/galaktoze ali primanjkljajem saharaze-izomaltaze tega zdravila ne smejo jemati.
The capsules should be swallowed whole and independent of food intake. 
Kapsule Diflucan je treba pogoltniti cele, s hrano ali brez nje.
Instructions for use: Shake the closed bottle of the suspension every time before using. 
Pred vsako uporabo zaprto plastenko s suspenzijo stresajte.
800 mg on Day 1 Subsequent dose: 400 mg daily 
Polnilni odmerek: 800 mg prvi dan Poznejši odmerki: 400 mg na dan
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON (10 mg/ml powder for oral suspension - 60 ml and 175 ml bottles) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (10 mg/ml prašek za peroralno suspenzijo - 60 ml in 175 ml plastenke)
Cisapride: There have been reports of cardiac events including torsades de pointes in patients to whom fluconazole and cisapride were coadministered. 
Cisaprid: Pri bolnikih, ki so sočasno dobivali flukonazol in cisaprid, so opisani učinki na srce, vključno s torsades de pointes.
Excipient: each ml also contains 9 mg sodium chloride (equivalent to 0.154 mmol sodium). 
Pomožne snovi: en ml vsebuje tudi 9 mg natrijevega klorida (ustreza 0,154 mmolom natrija) Za celoten seznam pomožnih snovi glejte poglavje 6.1.
• Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse. 
• Ponovitve kandidoze ustne votline in žrela ali kandidoze požiralnika pri bolnikih, okuženih s HIV, pri katerih obstaja visoko tveganje, da bo prišlo do ponovitve.
- decreased appetite - inability to sleep, feeling drowsy - fit, dizziness, sensation of spinning, tingling, pricking or numbness, changes in sense of taste - constipation, difficult digestion, wind, dry mouth - muscle pain - liver damage and yellowing of the skin and eyes (jaundice) - wheals, blistering (hives), itching, increased sweating - tiredness, general feeling of being unwell, fever 
spremembe v zaznavanju okusa - zaprtje, težave s prebavo, vetrovi, suha usta - bolečine v mišicah - okvara jeter in porumenelost kože ali oči (zlatenica) - gnojni mehurčki, pojavljanje mehurjev (koprivnica), srbenje, povečano znojenje - utrujenost, splošno slabo počutje, povišana telesna temperatura
reddening of the skin or difficulty in breathing - are taking astemizole, terfenadine (antihistamine medicines for allergies) - are taking cisapride (used for stomach upsets) - are taking pimozide (used for treating mental illness) - are taking quinidine (used for treating heart arrhythmia) - are taking erythromycin, (an antibiotic for treating infections) 
- jemljete astemizol, terfenadin (antihistaminska zdravila za zdravljenje alergij) - jemljete cisaprid (uporablja se pri težavah z želodcem) - jemljete pimozid (uporablja se za zdravljenje duševnih obolenj) - jemljete kinidin (uporablja se za zdravljenje srčnih aritmij) - jemljete eritromicin (antibiotik za zdravljenje okužb).
Fluconazole is a potent inhibitor of cytochrome P450 (CYP) isoenzyme 2C9 and a moderate inhibitor of CYP3A4. 
Flukonazol je močan zaviralec izoencima 2C9 citokroma P450 (CYP) in zmeren zaviralec CYP3A4.
Dose adjustment of saquinavir may be necessary. 
Potrebna je lahko prilagoditev odmerka sakvinavirja.
Dose: 6 to 12 mg/kg daily 
Odmerek: 6 do 12 mg/kg na dan
Dose: 3 to 12 mg/kg daily 
Odmerek: 3 do 12 mg/kg na dan
A higher fluconazole plasma elimination half-life of approximately 24 hours was found after a single dose. 
Po posamičnem odmerku so ugotovili daljši razpolovni čas izločanja flukonazola iz plazme in sicer približno 24 ur.
For the 175 ml bottle: - Diflucan 10 mg/ml powder for oral suspension is a dry white to off-white powder. 
Za 175 ml plastenko: - Diflucan 10 mg/ml prašek za peroralno suspenzijo je suh, bel do belkast prašek.
- Diflucan 150 mg hard capsules have a turquoise blue body and a turquoise blue cap. 
- Diflucan 150 mg trde želatinske kapsule imajo turkiznomodro telo in turkiznomodro kapico.
Rinse the syringe after use. 
Po uporabi brizgo sperite.
The mean half-life (hours) was 74 (range 44-185) on day 1 which decreased, with time to a mean of 53 (range 30-131) on day 7 and 47 (range 27-68) on day 13. 
Povprečni razpolovni čas (v urah) je bil 1. dan 74 (razpon 44-185) in se je sčasoma skrajšal na povprečno 53 (razpon 30-131) 7. dan in 47 (razpon 27-68) 13. dan. Površina pod krivuljo (mikrogrami.h/ml) je bila 1. dan 271 (razpon 173-385) in se je 7. dan povečala na povprečno
HOW DIFLUCAN IS GIVEN 
KAKO SE ZDRAVILO DIFLUCAN DAJE
Coadministration of other medicinal products known to prolong the QT interval and which are metabolised via the cytochrome P450 (CYP) 3A4 such as cisapride, astemizole, pimozide, quinidine and erythromycin are contraindicated in patients receiving fluconazole (see sections 4.4 and 4.5). 
Pri bolnikih, ki dobivajo flukonazol, je kontraindicirana sočasna uporaba drugih zdravil, ki podaljšujejo interval QT in se presnavljajo preko citokroma P450 (CYP) 3A4, npr. cisaprida, astemizola, pimozida, kinidina in eritromicina (glejte poglavji 4.4 in 4.5).
A 5 ml measuring spoon and/or a 5 ml graduated syringe with a press-in bottle adaptor might also be provided with the 60 ml bottle. 
60 ml plastenki je lahko dodana tudi 5 ml merilna žlička in/ali 5 ml z merilom opremljena brizga z nastavkom za vstavljanje v plastenko.
To treat cryptococcal meningitis 
Za zdravljenje kriptokoknega meningitisa
50 mg daily 
50 mg na dan
Single dose 150 mg. 
Enkraten 150 mg odmerek.
150 mg as a single dose. 
150 mg v enkratnem odmerku.
- Prophylaxis of Candida in immunocompromised patients 
- Preprečevanje okužb s kandido pri bolnikih z oslabljenim imunskim sistemom
6 mg to 12 mg per kg of body weight 
6 mg do 12 mg na kg telesne mase
Diflucan is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis and cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. 
Zdravilo Diflucan se uporablja za zdravljenje kandidoze sluznic (ustna votlina in žrelo, požiralnik), invazivne kandidoze in kriptokoknega meningitisa in za preprečevanje okužb s kandido pri bolnikih z oslabljenim imunskim sistemom.
Diflucan and associated names 40 mg/ml powder for oral suspension: 
Diflucan 40 mg/ml prašek za peroralno suspenzijo:
Zidovudine: Fluconazole increases Cmax and AUC of zidovudine by 84% and 74%, respectively, due to an approx. 45% decrease in oral zidovudine clearance. 
Zidovudin: Flukonazol zaradi približno 45 % zmanjšanega očistka peroralno uporabljenega zidovudina poveča Cmax in AUC zidovudina za 84 % oziroma 74 %.
Powder for oral suspension 10 mg/ml (175 ml bottle): Store below 25°C. 
Prašek za peroralno suspenzijo 10 mg/ml (175 ml plastenka): Shranjujte pri temperaturi do 25 °C.
Indefinitely at a daily dose of 200 mg 
Neomejeno ob odmerku 200 mg na dan
3 mg to 12 mg per kg of body weight 
3 mg do 12 mg na kg telesne mase
1 ml of reconstituted suspension contains 40 mg fluconazole. 
1 ml za uporabo pripravljene (rekonstituirane) suspenzije vsebuje 40 mg flukonazola.
200 mg to 400 mg daily 
200 mg do 400 mg
Diflucan is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. 
Zdravilo Diflucan se uporablja za zdravljenje kandidoze sluznic (ustne votline in žrela, požiralnika), invazivne kandidoze, kriptokoknega meningitisa in za preprečevanje okužb s kandido pri bolnikih z oslabljenim imunskim sistemom.
You might also be given Diflucan to: - stop cryptococcal meningitis from coming back - stop mucosal trush from coming back - reduce recurrence of vaginal trush - stop you from getting an infection caused by Candida (if your immune system is weak and not working properly) 
Zdravilo Diflucan vam je bilo lahko predpisano tudi za to: - da bi preprečili ponovitev kriptokoknega meningitisa - da bi preprečili ponovitev okužbe sluznic - da bi zmanjšali možnost za ponovitev vaginalne okužbe - da bi preprečili, da bi pri vas prišlo do okužbe, ki jo povzroča kandida (v primeru, da je vaš imunski sistem oslabljen in ne deluje ustrezno)
See leaflet for further information. 
Za več podatkov glejte navodilo za uporabo zdravila.
develop severe skin reactions (itching, reddening of the skin or difficulty in breathing). 
Simptomi lahko vključujejo srbenje, pordečitev kože ali težave z dihanjem.
PHARMACEUTICAL FORM Solution for infusion 
FARMACEVTSKA OBLIKA peroralna raztopina
100 to 200 mg daily or 200 mg 3 times per week. 
100 do 200 mg na dan ali 200 mg 3-krat na teden
Drug eruption (see section 4.4), urticaria (see section 4.4), pruritus, increased sweating 
Izbruh izpuščaja zaradi zdravila (glejte poglavje 4.4), koprivnica (glejte poglavje 4.4), pruritus, povečano znojenje
• Relapse of cryptococcal meningitis in patients with high risk of recurrence. 
• Ponovitve kriptokoknega meningitisa pri bolnikih, pri katerih je tveganje za ponovitev visoko.
LIST OF EXCIPIENTS Also contains sucrose, glycerol. 
SEZNAM POMOŽNIH SNOVI Vsebuje tudi saharozo in glicerol.
What Diflucan 10 mg/ml and 40 mg/ml powder for oral suspension look like and contents of the pack: 
Izgled zdravila Diflucan 10 mg/ml in 40 mg/ml prašek za peroralno suspenzijo in vsebina pakiranja
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally] 
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM [glejte Prilogo I - izpolni država članica]
Concomitant intake of fluconazole 200 mg and midazolam 7.5 mg orally increased the midazolam AUC and half-life 3.7-fold and 2.2-fold, respectively. 
Sočasno jemanje flukonazola v odmerku 200 mg in midazolama v odmerku 7,5 mg peroralno je povečalo AUC midazolama 3,7-krat in razpolovni čas 2,2-krat.
Loading dose: 200 mg to 400 mg on Day 1 
Polnilni odmerek: 200 mg do 400 mg prvi dan
Colloidal silica anhydrous Magnesium stearate Sodium laurilsulfate 
Vsebina kapsule: laktoza monohidrat koruzni škrob brezvodni koloidni silicijev dioksid magnezijev stearat natrijev lavrilsulfat
Fluconazole 200 mg daily given concurrently with triazolam 0.25 mg orally increased the triazolam AUC and half-life 4.4-fold and 2.3-fold, respectively. 
Flukonazol je v odmerku 200 mg na dan, ki so ga dajali sočasno s triazolamom v odmerku 0,25 mg peroralno povečal AUC triazolama 4,4krat in razpolovni čas 2,3-krat.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING BOTTLE LABEL (10 mg/ml powder for oral suspension - 60 ml and 175 ml bottles) 
PODATKI, KI MORAJO BITI NAVEDENI NA PRIMARNI OVOJNINI OZNAČBA NA PLASTENKI (10 mg/ml prašek za peroralno suspenzijo - 60 ml in 175 ml plastenke)
No significant pharmacokinetic changes have been observed when tacrolimus is given intravenously. 
Če so takrolimus dajali intravensko, niso opazili nobenih pomembnih sprememb farmakokinetike.
Fluconazole is also an inhibitor of the isozyme CYP2C19. 
Flukonazol je prav tako zaviralec izoencima CYP2C19.
Dose: 6 mg/kg daily 
Odmerek: 6 mg/kg na dan
Each 50 ml solution for infusion contains 100 mg fluconazole. 
50 ml raztopine za infundiranje vsebuje 100 mg flukonazola.
Uncommon side effects which affect 1 to 10 users in 1,000 are listed below: - reduction in red blood cells which can make skin pale and cause weakness or breathlessness - decreased appetite - inability to sleep, feeling drowsy - fit, dizziness, sensation of spinning, tingling, pricking or numbness, changes in sense of taste - constipation, difficult digestion, wind, dry mouth - muscle pain - liver damage and yellowing of the skin and eyes (jaundice) - wheals, blistering (hives), itching, increased sweating - tiredness, general feeling of being unwell, fever 
Občasni neželeni učinki, ki prizadenejo 1 do 10 uporabnikov izmed 1.000 so navedeni spodaj: - zmanjšanje števila rdečih krvnih celic, zaradi česar je koža lahko bleda, pride pa lahko tudi do oslabelosti ali zasoplosti - zmanjšan apetit - nespečnost, občutek zaspanosti - napadi, podobni epileptičnim, omotica, občutek vrtenja, ščemenje, zbadanje ali odrevenelost,
- Diflucan 50 mg hard capsules have a white body and a turquoise blue cap. 
- Diflucan 50 mg trde želatinske kapsule imajo belo telo in turkiznomodro kapico.
Diflucan and associated names 10 mg/ml powder for oral suspension: 
Diflucan 10 mg/ml prašek za peroralno suspenzijo:
Sodium hydroxide (for pH adjustment) 
6.1 Seznam pomožnih snovi natrijev klorid voda za injekcije natrijev hidroksid (za uravnavanje pH)
SPECIAL STORAGE CONDITIONS Powder for oral suspension: Store below 25°C. 
Prašek za peroralno suspenzijo: Shranjujte pri temperaturi do 25 °C.
Therapy should be modified if signs of toxicity develop. 
Če se pojavijo toksični učinki, je treba zdravljenje prilagoditi.
The area under the curve (microgram.h/ml) was 271 (range 173-385) on day 1 and increased with a mean of 490 (range 292-734) on day 7 and decreased with a mean of 360 (range 167-566) on day 13. 
Povprečni razpolovni čas (v urah) je bil 1. dan 74 (razpon 44-185) in se je sčasoma skrajšal na povprečno 53 (razpon 30-131) 7. dan in 47 (razpon 27-68) 13. dan. Površina pod krivuljo (mikrogrami.h/ml) je bila 1. dan 271 (razpon 173-385) in se je 7. dan povečala na povprečno 490 (razpon 292-734), 13. dan pa se je zmanjšala na povprečno 360 (razpon 167-566).
Each 100 ml solution for infusion contains 200 mg fluconazole. 
100 ml raztopine za infundiranje vsebuje 200 mg flukonazola.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON (40 mg/ml powder for oral suspension - 60 ml bottle) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (40 mg/ml prašek za peroralno suspenzijo - 60 ml plastenka)
Each 200 ml solution for infusion contains 400 mg fluconazole. 
200 ml raztopine za infundiranje vsebuje 400 mg flukonazola.
Hepatobiliary system Diflucan should be administered with caution to patients with liver dysfunction. 
Jetra, žolčnik in žolčevodi Zdravilo Diflucan je treba uporabljati previdno pri bolnikih z okvaro jeter.
Everolimus: Although not studied in vivo or in vitro, fluconazole may increase serum concentrations of everolimus through inhibition of CYP3A4. 
Everolimus: Flukonazol lahko poveča koncentracijo everolimusa v serumu preko zavrtja CYP3A4, vendar in vivo in in vitro študij niso opravili.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS LABEL (IV - 30 ml glass vial) 
OZNAKA (IV - 30 ml steklene viale)
Diflucan should be administered with caution to patients with these potentially proarrhythmic conditions. 
Zdravilo Diflucan je treba pri bolnikih s temi stanji, ki lahko pripomorejo k nastanku motenj srčnega ritma, uporabljati previdno.
- Do not use Diflucan after the expiry date which is stated on the pack after EXP. 
- Zdravila Diflucan ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na plastenki po Uporabno do:.
Phenytoin: Fluconazole inhibits the hepatic metabolism of phenytoin. 
Fenitoin: Flukonazol zavira presnovo fenitoina v jetrih.
Titanium dioxide (E171) Erythrosin (E127) Patent blue V (E131) 
100 mg kapsule želatina titanov dioksid (E171) eritrozin (E127) patentno modro barvilo V (E131)
NAME OF THE MEDICINAL PRODUCT Diflucan and associated names (see Annex I) 10 mg/ml powder for oral suspension Diflucan and associated names (see Annex I) 40 mg/ml powder for oral suspension [See Annex I - To be completed nationally] 
Diflucan in povezana imena (glejte Dodatek I) 10 mg/ml prašek za peroralno suspenzijo Diflucan in povezana imena (glejte Dodatek I) 40 mg/ml prašek za peroralno suspenzijo [glejte Dodatek I - Izpolni država članica]
- This medicine has been prescribed for you. 
Zdravilo Diflucan vam je bilo lahko predpisano tudi za to:
MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally] 
IMETNIK DOVOLJENJA ZA PROMET [glejte Dodatek I - Izpolni država članica]
HOW TO STORE DIFLUCAN 
SHRANJEVANJE ZDRAVILA DIFLUCAN
LIST OF EXCIPIENTS Also contains sucrose. 
SEZNAM POMOŽNIH SNOVI Vsebuje tudi saharozo.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING PACKAGING CARTON (5 mg/ml oral solution) 
PODATKI NA ZUNANJI OVOJNINI ŠKATLA (5 mg/ml peroralna raztopina)
Store below 25°C - Powder for oral suspension (175 ml bottle): - Store the powder below 25°C. 
Shranjujte pri temperaturi do 25 °C - Prašek za peroralno suspenzijo (175 ml plastenka): - Plastenko shranjujte tesno zaprto.
INFORMATION IN BRAILLE Diflucan and associated names (see Annex I) 150 mg [To be completed nationally] 
PODATKI V BRAILLOVI PISAVI Diflucan in povezana imena (glejte Prilogo I) 150 mg [izpolni država članica]
There is no evidence of circulating metabolites. 
Dokazov o presnovkih v obtoku ni.
To treat internal fungal infections caused by Candida 800 mg on the first day then 400 mg once daily until you are told to stop 
800 mg prvi dan, nato 400 mg enkrat na dan, dokler vam zdravnik ne naroči, da z zdravljenjem prenehajte
The 150 mg hard gelatin capsule has a turquoise blue body and turquoise blue cap overprinted with “Pfizer” and the code “FLU-150” with black ink. 
150 mg trda želatinska kapsula ima turkiznomodro telo in turkiznomodro kapico, na obeh pa je s črnilom črne barve natisnjena oznaka "Pfizer" in šifra "FLU-150".
100 mg to 200 mg daily or 200 mg 3 times per week 
100 mg do 200 mg na dan ali 200 mg 3-krat na teden
Dosage adjustment of fentanyl may be necessary. 
Potrebna je lahko prilagoditev odmerka fentanila.
If a dose of Diflucan has been forgotten 
Če so vam pozabili dati odmerek zdravila Diflucan
Concomitant treatment with fluconazole and cisapride is contraindicated (see section 4.3). 
Sočasna uporaba flukonazola in cisaprida je kontraindicirana (glejte poglavje 4.3).
- Chronic mucocutaneous candidiasis 
- Kronična atrofična kandidoza
INFORMATION IN BRAILLE Diflucan and associated names (see Annex I) 5 mg/ml [To be completed nationally] 
PODATKI V BRAILLOVI PISAVI Diflucan in povezana imena (glejte Prilogo I) 5 mg/ml [izpolni država članica]
HMG-CoA reductase inhibitors should be discontinued if a marked increase in creatinine kinase is observed or myopathy/rhabdomyolysis is diagnosed or suspected. 
Če pride do izrazitega povečanja koncentracije kreatin-kinaze, ali če se pojavi miopatija/rabdomioliza oziroma obstaja sum nanjo, je treba z uporabo zaviralcev reduktaze HMG-CoA prenehati.
The 50 mg hard gelatin capsule has a white body and a turquoise blue cap overprinted with “Pfizer” and the code “FLU-50” with black ink. 
50 mg trda želatinska kapsula ima belo telo in turkiznomodro kapico, na obeh pa je s črnilom črne barve natisnjena oznaka "Pfizer" in šifra "FLU-50".
Coadministration of fluconazole and pimozide is contraindicated (see section 4.3). 
Sočasna uporaba flukonazola in pimozida je kontraindicirana (glejte poglavje 4.3).
Important information about some of the ingredients of Diflucan Diflucan powder for oral suspension contains sucrose (sugar). 
Zdravilo Diflucan prašek za peroralno suspenzijo vsebuje saharozo (sladkor).
Coadministration of fluconazole and astemizole is contraindicated (see section 4.3). 
Sočasna uporaba flukonazola in astemizola je kontraindicirana (glejte poglavje 4.3).
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING BOTTLE LABEL(40 mg/ml powder for oral suspension - 60 ml bottle) 
PODATKI, KI MORAJO BITI NAVEDENI NA PRIMARNI OVOJNINI OZNAČBA NA PLASTENKI (40 mg/ml prašek za peroralno suspenzijo - 60 ml plastenka)
INFORMATION IN BRAILLE Diflucan and associated names (see Annex I) 10 mg/ml [To be completed nationally] 
PODATKI V BRAILLOVI PISAVI Diflucan in povezana imena (glejte Prilogo I) 10 mg/ml [izpolni država članica]
• Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis. 
• Kandidoze sluznic, vključno s kandidozo ustne votline in žrela, kandidoze požiralnika,
Abdominal pain, vomiting, diarrhoea, nausea 
Bolečine v trebuhu, bruhanje, driska, navzea
150 mg as a single dose 
150 mg v enkratnem odmerku
NAME OF THE MEDICINAL PRODUCT Diflucan and associated names (see Annex I) 150 mg hard capsules [See Annex I - To be completed nationally] 
Diflucan in povezana imena (glejte Dodatek I) 150 mg trde kapsule [glejte Dodatek I - Izpolni država članica]
INFORMATION IN BRAILLE Diflucan and associated names (see Annex I) 40 mg/ml [To be completed nationally] 
PODATKI V BRAILLOVI PISAVI Diflucan in povezana imena (glejte Prilogo I) 40 mg/ml [izpolni država članica]
Marketing Authorisation Holder and Manufacturer [See Annex I - To be completed nationally] 
Imetnik dovoljenja za promet z zdravilom in izdelovalec [glejte dodatek I - Izpolni država članica]
- red or purple discoloration of the skin which may be caused by low platelet count, other blood cell changes - blood chemistry changes (high blood levels of cholesterol, fats) - low blood potassium, - shaking - abnormal electrocardiogram (ECG), change in heart rate or rhythm - liver failure - allergic reactions (sometimes severe), including widespread blistering rash and skin peeling, 
- nizka koncentracija kalija v krvi - spremembe v kemijski sestavi krvi (visoke ravni holesterola in maščob v krvi) - tresavica - nenormalen elektrokardiogram (EKG), spremembe v hitrosti srčnega utripa ali pri ritmu delovanja srca - odpoved delovanja jeter - alergijske reakcije (včasih hude), vključno z obsežnimi mehurjastimi izpuščaji in luščenjem kože, hude kožne reakcije, otekanje ustnic ali obraza - izpadanje las
You might be given this medicine by your doctor to treat the following types of fungal infections: - Cryptococcal meningitis - a fungal infection in the brain - Coccidioidomycosis - a disease of the bronchopulmonary system - Infections caused by Candida and found in the blood stream, body organs (e.g. heart, lungs) or urinary tract - Mucosal thrush - infection affecting the lining of the mouth, throat and denture sore mouth 
- Kriptokokni meningitis - glivična okužba v možganih - Kokcidioidomikoza - bolezen bronhopulmonalnega sistema - Okužbe, povzročene s kandido, ugotovljene v krvnem obtoku, telesnih organih (npr. srce,
Coadministration of fluconazole and erythromycin is contraindicated (see section 4.3). 
Sočasna uporaba flukonazola in eritromicina je kontraindicirana (glejte poglavje 4.3).
Saquinavir: Fluconazole increases the AUC and C max of saquinavir with approximately 50% and 55% respectively, due to inhibition of saquinavir's hepatic metabolism by CYP3A4 and inhibition of P-glycoprotein. 
Sakvinavir: Zaradi zavrtja presnove sakvinavirja s CYP3A4 v jetrih in zavrtja P-glikoproteina flukonazol poveča AUC sakvinavirja za približno 50 % in Cmax za približno 55 %.
STATEMENT OF ACTIVE SUBSTANCE(S) 1 ml of oral solution contains 5 mg of fluconazole. 
NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN 1 ml peroralne raztopine vsebuje 5 mg flukonazola.
GENERAL CLASSIFICATION FOR SUPPLY [To be completed nationally] 
NAČIN IZDAJANJA ZDRAVILA [izpolni država članica]
The signs of liver problems include: tiredness loss of appetite vomiting yellowing of your skin or the whites of your eyes (jaundice) If any of these happen, stop taking Diflucan and tell your doctor immediately. 
Simptomi težav z jetri so naslednji: - utrujenost - izguba apetita - bruhanje - porumenelost kože ali očesnih beločnic (zlatenica).
Adjustment of dose of NSAIDs may be needed. 
Potrebna je lahko prilagoditev odmerka nesteroidnih protivnetnih zdravil.